What one share of Lexaria Bioscience holds
Lexaria Bioscience Corp. is a biotechnology company dedicated to the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients (“APIs”) using our patented DehydraTECHTM drug delivery technology.
Lexaria Bioscience’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-05-31; the balance sheet is as of 2026-05-31.
| Sales | $0.01 |
|---|---|
| Profit | −$0.34 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.33 |
| Cash and investments | $0.14 |
| Book value | $0.19 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | — | −$1.20 | — | — | — | $5.00 |
| 2011 | — | −$1.20 | — | — | — | $4.86 |
| 2015 | $0.01 | −$1.20 | $0.00 | −$1.13 | — | $0.53 |
| 2016 | $0.03 | −$0.90 | $0.00 | −$0.45 | — | $0.16 |
| 2017 | $0.03 | −$0.90 | $0.00 | −$0.79 | — | $1.22 |
| 2018 | $0.18 | −$2.70 | — | — | — | $0.95 |
| 2019 | $0.09 | −$1.50 | $0.25 | −$1.41 | — | $0.95 |
| 2020 | $0.11 | −$1.47 | $0.00 | −$0.94 | — | $0.83 |
| 2021 | $0.16 | −$0.95 | — | — | — | $2.32 |
| 2023 | $0.03 | −$1.01 | $0.01 | −$0.89 | — | $0.38 |
| 2024 | $0.04 | −$0.47 | $0.00 | −$0.40 | — | $0.51 |
| 2025 | $0.04 | −$0.66 | $0.00 | −$0.58 | — | $0.15 |
Common questions about Lexaria Bioscience
How much does one share of Lexaria Bioscience earn?
Over the last 12 months, Lexaria Bioscience lost $0.34 for each share on $0.01 of sales.
Does Lexaria Bioscience pay a dividend?
Lexaria Bioscience didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Lexaria Bioscience’s book value per share?
Lexaria Bioscience’s book value is $0.19 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of May 31, 2026.
How much cash and debt does each share of Lexaria Bioscience have?
Each share of Lexaria Bioscience has $0.14 of cash and investments, as of May 31, 2026.
What is Lexaria Bioscience’s free cash flow per share?
−$0.33 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Lexaria Bioscience bought back shares?
Lexaria Bioscience’s share count rose about 4281% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.